Evaluation of the efficacy and safety of orally administered BI425809 during a 12‐week treatment period compared with placebo in patients with cognitive impairment due to Alzheimer’s disease
Abstract:Background
Although currently approved therapies for Alzheimer’s dementia (AD) are used to treat impairments in memory and function, there is an unmet need for additional symptomatic therapies in mild‐to‐moderate AD. As N‐methyl‐D‐aspartate (NMDA) receptor hypofunction has been hypothesised to be associated with cognitive impairment in AD, improving post‐synaptic NMDA receptor signalling through glycine transporter 1 (GlyT1) inhibition may improve cognitive function. This proof of clinical concept study invest… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.